Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain

Primary aim was to assess prevalence and severity of potential and real drug–drug interactions (DDIs) among therapies for COVID-19 and concomitant medications in hospitalized patients with confirmed SARS-CoV-2 infection. The secondary aim was to analyze factors associated with rDDIs. An observationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantudo-Cuenca, M. D., Gutiérrez-Pizarraya, Antonio, Pinilla-Fernández, Ana, Contreras-Macías, Enrique, Fernández‑Fuertes, M., Lao‑Domínguez, F. A, Rincón, Pilar, Pineda, Juan Antonio, Macías, Juan, Morillo-Verdugo, Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203634/
https://www.ncbi.nlm.nih.gov/pubmed/34127740
http://dx.doi.org/10.1038/s41598-021-91953-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203634/
https://www.ncbi.nlm.nih.gov/pubmed/34127740
http://dx.doi.org/10.1038/s41598-021-91953-2

Ejemplares similares